236 related articles for article (PubMed ID: 31644577)
1. Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis.
Surendra NK; Abdul Manaf MR; Hooi LS; Bavanandan S; Mohamad Nor FS; Firdaus Khan SS; Meng OL; Abdul Gafor AH
PLoS One; 2019; 14(10):e0218422. PubMed ID: 31644577
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
[TBL] [Abstract][Full Text] [Related]
4. Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease.
Thaweethamcharoen T; Sritippayawan S; Noparatayaporn P; Aiyasanon N
Value Health Reg Issues; 2020 May; 21():181-187. PubMed ID: 32044691
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness evaluation of the Ministry of Health Malaysia dialysis programme.
Lim TO; Lim YN; Wong HS; Ahmad G; Singam TS; Morad Z; Suleiman AB; Rozina G; Ong LM; Hooi LS; Shaariah W; Tan CC; Loo CS
Med J Malaysia; 1999 Dec; 54(4):442-52. PubMed ID: 11072461
[TBL] [Abstract][Full Text] [Related]
6. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
7. Health related quality of life of dialysis patients in Malaysia: Haemodialysis versus continuous ambulatory peritoneal dialysis.
Surendra NK; Abdul Manaf MR; Hooi LS; Bavanandan S; Mohamad Nor FS; Shah Firdaus Khan S; Ong LM; Abdul Gafor AH
BMC Nephrol; 2019 Apr; 20(1):151. PubMed ID: 31039745
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
Teerawattananon Y; Mugford M; Tangcharoensathien V
Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness of interventions for end-stage renal disease].
Arredondo A; Rangel R; de Icaza E
Rev Saude Publica; 1998 Dec; 32(6):556-65. PubMed ID: 10349148
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of three dialysis methods in patients with end-stage renal disease in China.
Hong Z; Zhuang Y; Lu J; Ye J; Sun H; Gao L; Xiong Y
Int Urol Nephrol; 2023 May; 55(5):1247-1254. PubMed ID: 36376531
[TBL] [Abstract][Full Text] [Related]
11. Health economic evaluations: the special case of end-stage renal disease treatment.
Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
[TBL] [Abstract][Full Text] [Related]
12. Dialysis for end-stage renal disease. Determining a cost-effective approach.
Kirby L; Vale L
Int J Technol Assess Health Care; 2001; 17(2):181-9. PubMed ID: 11446130
[TBL] [Abstract][Full Text] [Related]
13. Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis.
Salonen T; Reina T; Oksa H; Rissanen P; Pasternack A
Int Urol Nephrol; 2007; 39(1):289-98. PubMed ID: 17333524
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
Beby AT; Cornelis T; Zinck R; Liu FX
Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
Yang F; Devlin N; Luo N
Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis.
Cortés-Sanabria L; Paredes-Ceseña CA; Herrera-Llamas RM; Cruz-Bueno Y; Soto-Molina H; Pazarín L; Cortés M; Martínez-Ramírez HR
Arch Med Res; 2013 Nov; 44(8):655-61. PubMed ID: 24211750
[TBL] [Abstract][Full Text] [Related]
17. Financial implications of dialysis modalities in the developing world: A Chinese perspective.
Liu J; Hutton DW; Gu Y; Hu Y; Li Y; Ma L; Zeng X; Fu P
Perit Dial Int; 2020 Mar; 40(2):193-201. PubMed ID: 32063196
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?
Yousefi M; Rezaei S; Hajebrahimi S; Falsafi N; Keshvari-Shad F
BMC Nephrol; 2024 Mar; 25(1):85. PubMed ID: 38448887
[TBL] [Abstract][Full Text] [Related]
19. Cost analysis of renal replacement therapies in Finland.
Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
[TBL] [Abstract][Full Text] [Related]
20. Supporting dialysis policy for end stage renal disease (ESRD) in Indonesia: an updated cost-effectiveness model.
Putri S; Nugraha RR; Pujiyanti E; Thabrany H; Hasnur H; Istanti ND; Evasari D; Afiatin
BMC Res Notes; 2022 Dec; 15(1):359. PubMed ID: 36474238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
